Office of Biotechnology Activities
|
National Institutes of Health - Office of Science Policy
|
|
RAC June 21, 2002 - Presentation Materials |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Call to Order |
|
|
|
Theodore Friedmann, M.D., RAC Chair |
|
|
|
Webcast
|
|
|
|
|
Presentation of RAC Member Certificates and Induction of New RAC Members |
|
|
|
Ruth L. Kirschstein, M.D., Deputy Director, NIH
Amy Patterson, M.D., OBA Director
|
|
|
|
Webcast
|
|
|
|
|
Discussion of Human Gene Transfer Protocol #0112-533 entitled: |
|
|
|
Phase I Trial of in situ Gene Therapy for Locally Recurrent Prostate Cancer Following Radiation Therapy Failure Using Sodium/Iodide Symporter and Radioiodine |
|
|
|
John Morris, M.D., Mayo Clinic
|
|
|
|
Slides
Webcast
|
|
|
|
Reviewers:
Larry Johnson, M.D.
James Childress, Ph.D.
Theodore Friedmann, M.D.
|
|
|
|
Slides
|
|
|
|
|
Data Management Report |
|
|
|
Webcast
|
|
|
|
|
Discussion of Human Gene Transfer Protocol #0201-534 entitled |
|
|
|
Phase I Study of AD4-"E3-HIVenv and AD4-"E3-HIVgag/pro Recombinant Vaccines in HIV-Negative Volunteers |
|
|
|
Mark Connors, M.D., National Institute of Allergy and Infectious Diseases
|
|
|
|
Slides
Webcast
|
|
|
|
|
ADJOURN |
|
|
|
Top of Page |
|
|
|
|
|
|
|